Back to trial detailsIntake questionnaire
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Applying to University of Kansas Medical Center · Kansas City, Kansas
Answer a few short questions to share with the research team.
0 of 4 answered